BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31273338)

  • 1. The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway.
    Zhu Y; He D; Bo H; Liu Z; Xiao M; Xiang L; Zhou J; Liu Y; Liu X; Gong L; Ma Y; Zhou Y; Zhou M; Xiong W; Yang F; Xing X; Li R; Li W; Cao K
    Oncogene; 2019 Aug; 38(32):6065-6081. PubMed ID: 31273338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma.
    Zheng YJ; Zhao JY; Liang TS; Wang P; Wang J; Yang DK; Liu ZS
    FASEB J; 2019 Nov; 33(11):12915-12928. PubMed ID: 31557058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA PTPRG-AS1 acts as a microRNA-194-3p sponge to regulate radiosensitivity and metastasis of nasopharyngeal carcinoma cells via PRC1.
    Yi L; Ouyang L; Wang S; Li SS; Yang XM
    J Cell Physiol; 2019 Aug; 234(10):19088-19102. PubMed ID: 30993702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SP1-induced AFAP1-AS1 contributes to proliferation and invasion by regulating miR-497-5p/CELF1 pathway in nasopharyngeal carcinoma.
    Jin H; Liang G; Yang L; Liu L; Wang B; Yan F
    Hum Cell; 2021 Mar; 34(2):491-501. PubMed ID: 33400247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
    Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
    BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis.
    Wang Q; Zhang W; Hao S
    Cell Cycle; 2017 Apr; 16(8):795-801. PubMed ID: 28358263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles derived from paclitaxel-sensitive nasopharyngeal carcinoma cells deliver miR-183-5p and impart paclitaxel sensitivity through a mechanism involving P-gp.
    Cui X; Chen Y; Zhao L; Ding X
    Cell Biol Toxicol; 2023 Dec; 39(6):2953-2970. PubMed ID: 37296288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells.
    Li S; Zhang X; Zhang R; Liang Z; Liao W; Du Z; Gao C; Liu F; Fan Y; Hong H
    Cell Cycle; 2017; 16(17):1601-1610. PubMed ID: 28749195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neferine sensitized Taxol-resistant nasopharygeal carcinoma to Taxol by inhibiting EMT via downregulating miR-130b-5p.
    Wang X; Wang K; Xiao J; Song Y; Li H
    Biochem Biophys Res Commun; 2020 Oct; 531(4):573-580. PubMed ID: 32811645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA FOXD2-AS1 aggravates nasopharyngeal carcinoma carcinogenesis by modulating miR-363-5p/S100A1 pathway.
    Chen G; Sun W; Hua X; Zeng W; Yang L
    Gene; 2018 Mar; 645():76-84. PubMed ID: 29248577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo.
    Peng X; Cao P; Li J; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
    Cancer Biol Ther; 2015; 16(2):261-7. PubMed ID: 25756509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-Mediated Transfer of ALDH2 in Nasopharyngeal Carcinoma Cells Confers Increased Resistance to Paclitaxel Treatment.
    Yan J; Wu L; Zheng M; Pan F
    Discov Med; 2024 Jun; 36(185):1210-1220. PubMed ID: 38926107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing long non-coding RNA H19 combined with paclitaxel inhibits nasopharyngeal carcinoma progression.
    Zhu H
    Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110249. PubMed ID: 32736275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway.
    Li T; Li Y
    Immunobiology; 2023 Mar; 228(2):152324. PubMed ID: 36608594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA PXN-AS1-L promotes the malignancy of nasopharyngeal carcinoma cells via upregulation of SAPCD2.
    Jia X; Niu P; Xie C; Liu H
    Cancer Med; 2019 Aug; 8(9):4278-4291. PubMed ID: 31173488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho/Rac pathway.
    Lian Y; Xiong F; Yang L; Bo H; Gong Z; Wang Y; Wei F; Tang Y; Li X; Liao Q; Wang H; Zhou M; Xiang B; Wu X; Li Y; Li X; Chen X; Li G; Guo C; Zeng Z; Xiong W
    J Exp Clin Cancer Res; 2018 Oct; 37(1):253. PubMed ID: 30326930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 18. MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo.
    Peng X; Cao P; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
    Int J Clin Exp Pathol; 2014; 7(10):6784-91. PubMed ID: 25400759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted regulationof STAT3 by miR-29a in mediating Taxol resistance of nasopharyngeal carcinoma cell line CNE-1.
    Gao J; Shao Z; Yan M; Fu T; Zhang L; Yan Y
    Cancer Biomark; 2018; 22(4):641-648. PubMed ID: 29914005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
    Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
    Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.